In this spotlight article, presented by BioInsights, Dr. Ramin Baghirzade, AGC Biologics' Global Head of Business Development for Cell & Gene Therapy, shares his expert insights on the state of the industry, and four inter-connected variables exerting pressure on therapeutics developers to improve their processes earlier in the product’s development.
He says of the current landscape, “As the industry matures, the speed to successful commercialization inevitably trumps the speed to market. The race to success in cell and gene therapy is a marathon, not a sprint.” Download your free copy to learn more.
Have any questions about this article? We're happy to help – contact us today. You can also learn more about our Center of Excellence for our Cell and Gene Therapy offering by visiting our Milan facility page.
